| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Imugene (ASX; IMU) is an immuno-oncology focused biopharmaceutical company developing HER-2+ gastric and breast cancer immunotherapies. |
| Category: | Health & biotech |
| URL: | http://www.imugene.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | IMU |
| Year of Commencement: | 2000 |
| Address: | Sydney Nsw |
| State: | New South Wales |
| Overseas Operations: | No |
| Twitter: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/imugene |
| Founders: | |
| Awards won: | |
